Effect of Homozygous MTHFR A1298C (1298 CC) on Lipid Metabolism
The homozygous MTHFR A1298C (1298 CC) genotype is associated with lower HDL cholesterol levels and elevated LDL cholesterol, particularly when combined with hypermethylation of the MTHFR promoter region.
Primary Lipid Effects
The MTHFR 1298 CC genotype demonstrates consistent detrimental effects on lipid profiles:
HDL cholesterol is significantly reduced in individuals carrying the A1298C variant compared to wild-type (1298 AA). The wild-type genotype shows HDL levels of 50.9±1.6 mg/dL versus 47.1±1.0 mg/dL in variants (p=0.036), with an odds ratio of 0.963 (95% CI 0.93-0.99) for lower HDL 1.
LDL cholesterol levels are elevated in carriers of the 1298 AC/CC genotypes, with this effect being independent of the C677T polymorphism 2.
Total cholesterol is significantly higher when the 1298 AA genotype is combined with MTHFR promoter hypermethylation (p=0.0001 for total cholesterol, p=0.0006 for LDL cholesterol) 3.
Mechanistic Considerations
The lipid alterations occur through several pathways:
The A1298C polymorphism affects folate metabolism differently than the more commonly studied C677T variant. While C677T creates a thermolabile enzyme, A1298C produces a thermostable form that still impacts metabolic function 4. The reduction in HDL with 1298 variants occurs independently of any linkage disequilibrium with C677T or interaction between the two polymorphisms 1.
Synergistic Risk Factors
Critical caveat: The lipid effects are substantially amplified by environmental and metabolic factors:
Low folate status combined with any MTHFR polymorphism (including A1298C) increases odds of hypertriglyceridemia (OR=2.02,95% CI 1.25-3.25) and low HDL (OR=1.88,95% CI 1.07-3.28) 5.
Promoter hypermethylation in the presence of 1298 AA genotype shows the most pronounced effects on total cholesterol and LDL, suggesting epigenetic modifications modulate the genetic impact 3.
Insulin resistance is worsened by the A1298C polymorphism, with detrimental effects on HOMA-IR in recurrent spontaneous abortion patients carrying the variant 2.
Clinical Implications for Lipid Management
For individuals with homozygous MTHFR 1298 CC:
- Monitor HDL cholesterol more closely, as this is the most consistently affected parameter
- Assess total cholesterol and LDL, particularly if other risk factors are present
- Check folate status, as low folate synergistically worsens dyslipidemia 5
- Consider 5-methyltetrahydrofolate supplementation rather than folic acid, as this bypasses the need for MTHFR enzyme conversion 6
The interaction between MTHFR A1298C and MTRR A66G polymorphisms also influences lipid profiles, with combined variants showing additive effects on dyslipidemia risk 2, 5.